Advertisement

Index by author

February 01, 1994; Volume 45,Issue 2

  1. Hass, N A

    1. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
      H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology February 1994, 45 (2) 176-181;

  2. Henningsen, R A

    1. Release of dopamine via the human transporter.
      A J Eshleman, R A Henningsen, K A Neve and A Janowsky
      Molecular Pharmacology February 1994, 45 (2) 312-316;

  3. Heuillet, E

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  4. Hirata, M

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

  5. Hiratsuka, A

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  6. Hughes, L

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;
Back to top

In this issue

Advertisement